Monoclonal antibodies to prevent respiratory syncytial virus (RSV) infection

References

Citations

  1. American Academy of Pediatrics (2003). Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infection. Pediatrics, 112(6): 1447–1452. Also available online: http://aappolicy.aappublications.org/cgi/reprint/pediatrics;112/6/1447.pdf.

  2. Lozano JM (2005). Bronchiolitis. Clinical Evidence (14): 1–15.


Author: Amy Fackler, MA
Debby Golonka, MPH		Last Updated: August 9, 2006
Medical Review: Kathleen Romito, MD - Family Medicine
Michael J. Sexton, MD - Pediatrics
W. David Colby IV, MSc, MD, FRCPC - Infectious Disease

© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

Click here to learn about Healthwise

Topic Contents
 Examples
 How It Works
 Why It Is Used
 How Well It Works
 Side Effects
 What To Think About
 References